Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Patnaik

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Pharmaceutical Research|January 12, 2002
Bioavailability and bioequivalence: an FDA regulatory overviewM L Chen, V Shah, R Patnaik, et al.
Indian Journal of Dermatology, Venereology and Leprology|October 16, 2010
Fluticasone propionate (0.05%) cream compared to betamethasone valerate (0.12%) cream in the treatment of steroid-responsive dermatoses: a multicentric studyP Jamkhedkar, C Shenai, H J Shroff, et al.
Pharmaceutical Research|November 1, 1996
Evaluation of orally administered highly variable drugs and drug formulationsV P Shah, A Yacobi, W H Barr, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Pharmaceutical Research|January 12, 2002
Bioavailability and bioequivalence: an FDA regulatory overviewM L Chen, V Shah, R Patnaik, et al.
Indian Journal of Dermatology, Venereology and Leprology|October 16, 2010
Fluticasone propionate (0.05%) cream compared to betamethasone valerate (0.12%) cream in the treatment of steroid-responsive dermatoses: a multicentric studyP Jamkhedkar, C Shenai, H J Shroff, et al.
Pharmaceutical Research|November 1, 1996
Evaluation of orally administered highly variable drugs and drug formulationsV P Shah, A Yacobi, W H Barr, et al.
Pageof 10